Lb Pharmaceuticals LBRX
NASDAQ LBRX
$41.00 +2.19 (+5.64%)
At close: Oct 20, 2026 · 4:00 PM EDT

Lb Pharmaceuticals (LBRX) EPS (Diluted) (2024 - 2026)

Updated

Lb Pharmaceuticals' EPS (Diluted) came in at -$1.71 for Q2 2026, compared with -$13.58 a year earlier.

Analysis

Lb Pharmaceuticals (LBRX) EPS (Diluted) (2024 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Lb Pharmaceuticals reported EPS (Diluted) of -$2.01; for FY2025, it was $0.00.

  • Going back by year, EPS (Diluted) was -$0.18 in FY2024.
  • The five-year range for quarterly EPS (Diluted) is -$39.49 (Q3 2024) to $161.82 (Q4 2024).
  • Business Quant data shows LBRX's EPS (Diluted) at -$0.67 (Q1 2026), $1.70 (Q4 2025) and -$0.61 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 7.94
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 2.27
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 2.04
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -0.54
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 1.67
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 1.60
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 4.37
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -8.44
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -0.04
10 Lb Pharmaceuticals 1.23 Bn -73.20 Mn - -1.71
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.71
Mar 31, 2026 -0.67
Dec 31, 2025 1.70
Sep 30, 2025 -0.61
Jun 30, 2025 -13.58
Mar 31, 2025 -14.79
Dec 31, 2024 161.82
Sep 30, 2024 -39.49
API Access

Lb Pharmaceuticals EPS (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-diluted&ticker=LBRX&period=max&api_key=YOUR_API_KEY